Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Unregistered Sales of Equity Securities

None.

Common Stock

Our common stock is traded on the New York Stock Exchange under the symbol “FCX.” At January 31, 2022, there were 10,719 holders of record of our common stock.

Common Stock Dividends

In February 2021, our Board of Directors (the Board) reinstated a cash dividend on our common stock (base dividend) at an annual rate of $0.30 per share, and on November 1, 2021, the Board approved a variable cash dividend on our common stock for 2022 at an expected annual rate of $0.30 per share. The combined annual rate of the base dividend and the variable dividend is expected to total $0.60 per share for 2022.

On December 22, 2021, the Board declared cash dividends totaling $0.15 per share (which included the $0.075 per share quarterly base cash dividend and the $0.075 per share variable cash dividend) on our common stock, which was paid on February 1, 2022, to shareholders of record as of January 14, 2022. The declaration and payment of dividends (base or variable) is at the discretion of our Board and will depend upon our financial results, cash requirements, business prospects, global economic conditions and other factors deemed relevant by our Board. See “Cautionary Statement” in Items 7. and 7A. “Management’s Discussion and Analysis of Financial Condition and Results of Operations and Quantitative and Qualitative Disclosures About Market Risk” and Note 10 for further discussion.

Issuer Purchases of Equity Securities

In November 2021, our Board approved a new share repurchase program, which authorizes repurchases of up to $3.0 billion of our common stock. The timing and amount of the share repurchases is at the discretion of management and will depend on a variety of factors. The program may be modified, increased, suspended or terminated at any time at the Board’s discretion. See Note 10 for further discussion.

Table of Contents

The following table summarizes share repurchases made by us during the three months ended December 31, 2021, and the approximate dollar value of shares that may yet be purchased pursuant to our share repurchase program:

a.On November 1, 2021, our Board approved a new share repurchase program authorizing repurchases of up to $3.0 billion of our common stock. This new share repurchase program superseded and replaced the share repurchase program previously authorized by our Board in July 2008. The new share repurchase program does not obligate us to acquire any specific amount of shares and does not have an expiration date.

b.Includes 455,734 shares acquired in connection with stock option exercises during the period shown. All other share repurchases were made under our publicly announced program.